Vital KSK Holdings Incorporation operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vital KSK Holdings Incorporation with three other
drug stores in Asia:
Hokuyaku Takeyama Holdings, Inc
sales of 225.15 billion Japanese Yen [US$2.18 billion]
of which 72%
was Pharmaceutical Business),
Hua Xia Healthcare Holdings Limited
of Hong Kong
(1.57 billion Hong Kong Dollars [US$202.97 million]
of which 84%
was Pharmaceutical Wholesale), and
Hai-O Enterprise Berhad
based in Malaysia
(297.63 million Malaysian Ringgits [US$70.98 million]
of which 67%
was Multi-Level Marketing).
Vital KSK Holdings Incorporation reported sales of ¥621.04 billion (US$6.01 billion)
March of 2016.
increase of 13.3%
versus 2015, when the company's sales were ¥548.01 billion.
Sales of Other saw an increase
21.7% in 2016, from
¥23.97 billion to ¥29.17 billion.